RGD-Functionalized ZIF-8 Nanocarriers Enable Highly Selective Delivery of Repurposed Gliclazide in Breast Cancer
ACS Applied Bio Materials · 29.05.2026
DOI: 10.1021/acsabm.6c00092 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 29.05.2026. Verfasst von Gaayatri Silvaraju und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering Technology, Faculty of Chemical and Process Engineering Technology, University of Malaysia Pahang Al-Sultan Abdull…. Hauptthemen laut MEDLINE: Oligopeptides, Breast Neoplasms, Antineoplastic Agents, Nanoparticles. Die Arbeit nennt 84 Literaturangaben. Gefördert von: Ministry of Higher Education, Malaysia.
Abstract (Originalsprache)
) while maintaining reduced toxicity toward MRC-5 normal fibroblasts, resulting in a markedly improved selectivity index. Overall, this work demonstrates that RGD-functionalized nZIF-8 is a promising pH-responsive and selective nanoplatform for the targeted delivery of repurposed therapeutics in breast cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering Technology, Faculty of Chemical and Process Engineering Technology, University of Malaysia Pahang Al-Sultan Abdullah (UMPSA), 26300 Gambang, Pahang, Malaysia.
- Department of Chemistry and Key Laboratory for Preparation and Application of Ordered Structural Materials of Guangdong Province, Shantou University, 515063 Guangdong, China.
- UPM-MAKNA Cancer Research Laboratory (CANRES), Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.
- Medical Technology Division, Malaysian Nuclear Agency, 43000 Kajang, Selangor, Malaysia.
ORCID-Profile: Nurul Akmarina Mohd Abdul Kamal
Förderung
- Ministry of Higher Education, Malaysia
Zitieren
APA
Silvaraju, G., Borzehandani, M. Y., Johari, N. A. S., Saad, N., Razali, R., Shaarani, S. H. N., & Kamal, N. A. M. A. (2026). RGD-Functionalized ZIF-8 Nanocarriers Enable Highly Selective Delivery of Repurposed Gliclazide in Breast Cancer. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00092
Vancouver
Silvaraju G, Borzehandani MY, Johari NAS, Saad N, Razali R, Shaarani SHN, et al. RGD-Functionalized ZIF-8 Nanocarriers Enable Highly Selective Delivery of Repurposed Gliclazide in Breast Cancer. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00092
BibTeX
@article{Silvaraju2026,
author = {Silvaraju, Gaayatri and Borzehandani, Mostafa Yousefzadeh and Johari, Nur Airin Syahira and Saad, Norazalina and Razali, Rosniza and Shaarani, Siti Hajar Noor and Kamal, Nurul Akmarina Mohd Abdul},
title = {RGD-Functionalized ZIF-8 Nanocarriers Enable Highly Selective Delivery of Repurposed Gliclazide in Breast Cancer},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.6c00092}
}
EUVIMED